Forterra, Inc. (FRTA):企業の財務・戦略的SWOT分析

◆英語タイトル:Forterra, Inc. (FRTA) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA8010802
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:43
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:建設・不動産
◆販売価格オプション(消費税別)
Single UserUSD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Forterra, Inc. (FRTA) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Forterra, Inc. (Forterra) is a manufacturer of building materials. It produces and distributes pipe and precast products. The company’s product portfolio includes precast concrete structures, concrete drainage pipes, water distribution pipes, ductile iron pipes, concrete pressure pipes, storm water management systems, water transmission pipes and structural and specialty products. It also offers several key infrastructure components for various projects including residential, non-residential, and infrastructural construction. The company operates its production and distribution facilities in the US, Eastern Canada and Mexico; and fabrication plants in the US. The company primarily offers its products to municipalities, contractors, and distributors. Forterra is headquartered in Irving, Texas, the US.

Forterra, Inc. Key Recent Developments

Nov 08,2017: Forterra announces third quarter 2017 results
Sep 07,2017: Charlie Brown joins Forterra as Executive Vice President and Chief Financial Officer
Sep 07,2017: Charlie Brown Joins Forterra as Executive Vice President and Chief Financial Officer
Aug 10,2017: Forterra Announces Second Quarter 2017 Results
Aug 01,2017: Forterra appoints Chris Meyer as chairman of board

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1 – About the Company 5
Forterra, Inc. – Key Facts 5
Forterra, Inc. – Key Employees 6
Forterra, Inc. – Key Employee Biographies 7
Forterra, Inc. – Major Products and Services 8
Forterra, Inc. – History 9
Forterra, Inc. – Company Statement 10
Forterra, Inc. – Locations And Subsidiaries 11
Head Office 11
Other Locations & Subsidiaries 11
Section 2 – Company Analysis 13
Company Overview 13
Forterra, Inc. – Business Description 13
Forterra, Inc. – SWOT Analysis 14
SWOT Analysis – Overview 14
Forterra, Inc. – Strengths 14
Forterra, Inc. – Weaknesses 15
Forterra, Inc. – Opportunities 16
Forterra, Inc. – Threats 17
Forterra, Inc. – Key Competitors 18
Section 3 – Company Financial Ratios 19
Financial Ratios – Capital Market Ratios 19
Financial Ratios – Annual Ratios 20
Performance Chart 23
Financial Performance 23
Financial Ratios – Interim Ratios 24
Financial Ratios – Ratio Charts 25
Section 4 – Company’s Recent Developments 26
Nov 08, 2017: Forterra announces third quarter 2017 results 26
Sep 07, 2017: Charlie Brown Joins Forterra as Executive Vice President and Chief Financial Officer 27
Sep 07, 2017: Charlie Brown joins Forterra as Executive Vice President and Chief Financial Officer 28
Aug 10, 2017: Forterra Announces Second Quarter 2017 Results 29
May 15, 2017: Forterra Announces Its First Quarter 2017 Results 31
Mar 29, 2017: Forterra Announces Its Fourth Quarter and Full Year 2016 Results 33
Mar 29, 2017: Forterra announces fourth quarter and full year 2016 results 35
Jan 10, 2017: Scott Leonard joins Forterra as Executive Vice President and Chief Operating Officer 37
Nov 10, 2016: Forterra reports strong third quarter 2016 38
Section 5 – Appendix 39
Methodology 39
Ratio Definitions 39
About GlobalData 43
Contact Us 43
Disclaimer 43

List of Tables
Forterra, Inc., Key Facts 5
Forterra, Inc., Key Employees 6
Forterra, Inc., Key Employee Biographies 7
Forterra, Inc., Major Products and Services 8
Forterra, Inc., History 9
Forterra, Inc., Other Locations 11
Forterra, Inc., Subsidiaries 12
Forterra, Inc., Key Competitors 18
Forterra, Inc., Ratios based on current share price 19
Forterra, Inc., Annual Ratios 20
Forterra, Inc., Annual Ratios (Cont...1) 21
Forterra, Inc., Annual Ratios (Cont...2) 22
Forterra, Inc., Interim Ratios 24
Currency Codes 39
Capital Market Ratios 39
Equity Ratios 40
Profitability Ratios 40
Cost Ratios 41
Liquidity Ratios 41
Leverage Ratios 42
Efficiency Ratios 42

★海外企業調査レポート[Forterra, Inc. (FRTA):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Richoux Group Plc:企業の戦略・SWOT・財務情報
    Richoux Group Plc - Strategy, SWOT and Corporate Finance Report Summary Richoux Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Mitralign Inc:医療機器:M&Aディール及び事業提携情報
    Summary Mitralign Inc (Mitralign) is a medical device company that offers direct transcatheter annuloplasty system to treat both functional tricuspid regurgitation and mitral regurgitation. The company’s products include crossing wire, pledget delivery catheter and placation lock delivery catheter, …
  • GRI Bio Inc-製薬・医療分野:企業M&A・提携分析
    Summary GRI Bio Inc (GRI Bio) is a biotech company that develops and manufactures therapies for inflammatory diseases. The company develops Natural Killer T cell based therapies for the treatment of liver disease and autoimmune disoders. Its lead candidate GRI-0621, a novel oral therapeutic for live …
  • Meta Biomed Co Ltd (059210):企業の製品パイプライン分析2018
    Summary Meta Biomed Co Ltd (Meta Biomed) is a medical device company that develops and manufactures dental materials and equipments. The company provides suture, dental, bone and medical products. It offers various medical products such as endodontic materials, bone restorative materials, implant ma …
  • Daito Trust Construction Co., Ltd.:企業の戦略・SWOT・財務分析
    Daito Trust Construction Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Daito Trust Construction Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Pioneer Corporation:企業の戦略・SWOT・財務分析
    Pioneer Corporation - Strategy, SWOT and Corporate Finance Report Summary Pioneer Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Dynatronics Corp (DYNT):企業の財務・戦略的SWOT分析
    Summary Dynatronics Corp (Dynatronics) is a medical device company that offers physical therapy, aesthetics and medical products. The company offers hot and cold therapy, clinical accessories, body positioning, sports medicine, orthopedics, hand therapy, strength equipment, treatment tables and reha …
  • Worldpay Us Inc:企業の戦略・SWOT・財務分析
    Worldpay Us Inc - Strategy, SWOT and Corporate Finance Report Summary Worldpay Us Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Reckitt Benckiser Group plc:企業のM&A・事業提携・投資動向
    Reckitt Benckiser Group plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Reckitt Benckiser Group plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • Emerald Expositions, Inc. (EEX):企業の財務・戦略的SWOT分析
    Emerald Expositions, Inc. (EEX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Nippon Steel & Sumitomo Metal Corporation:企業のM&A・事業提携・投資動向
    Nippon Steel & Sumitomo Metal Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Nippon Steel & Sumitomo Metal Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detaile …
  • Verastem Inc (VSTM):医療機器:M&Aディール及び事業提携情報
    Summary Verastem Inc (Verastem) is a clinical-stage biopharmaceutical company with focus on the discovery, development and commercialization of drugs to treat cancer. The company’s lead product candidates include duvelisib, defactinib (VS-6063), FAK inhibitor (VS-4718) and PI3K/mTOR inhibitor (VS-55 …
  • Vantage Oncology Inc-製薬・医療分野:企業M&A・提携分析
    Summary Vantage Oncology Inc (Vantage Oncology), a subsidiary of McKesson Corp is a critical oncology service provider that owns and operates cancer treatment facilities. The company operates cancer treatment facilities in the US. It provides treatment for bone, brain, breast, gastrointestinal, gyne …
  • GVK Biosciences Pvt Ltd-医療機器分野:企業M&A・提携分析
    Summary GVK Biosciences Pvt Ltd (GVK BIO) is a contract research organization that offers contract manufacturing and research services. The organization provides services such as discovery services, integrated programs, clinical development, contract manufacturing, formulations and informatics. It p …
  • Thai Airways International Public Co Ltd:戦略・SWOT・企業財務分析
    Thai Airways International Public Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Thai Airways International Public Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Murray & Roberts Holdings Ltd (MUR):企業の財務・戦略的SWOT分析
    Murray & Roberts Holdings Ltd (MUR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Integra LifeSciences Holdings Corp (IART):医療機器:M&Aディール及び事業提携情報
    Summary Integra LifeSciences Holdings Corp (Integra) is a medical technology company, which offers engineered collagen-based product lines. The company’s portfolio consists of surgical instruments, advanced wound care and orthopedic hardware, specialty metal implants, dermal regeneration products, o …
  • TVA Medical Inc:医療機器:M&Aディール及び事業提携情報
    Summary TVA Medical Inc (TVA Medical) is a medical device company that designs and manufactures catheter-based systems. The company offers minimally invasive therapies for treatment of end stage renal disease. It offers everlinq, an endovascular device used for creating an AV fistula for hemodialysi …
  • ResApp Health Ltd (RAP):製薬・医療:M&Aディール及び事業提携情報
    Summary ResApp Health Ltd (ResApp) formerly, Narhex Life Sciences Limited is a digital health company that develops smartphone applications for the diagnosis and management of respiratory disease. It's digital healthcare solutions assist doctors and patients to diagnose and manage respiratory diseas …
  • Mayne Pharma Group Ltd (MYX):企業の財務・戦略的SWOT分析
    Summary Mayne Pharma Group Ltd (Mayne Pharma), formerly HalcyGen Pharmaceuticals Ltd, a subsidiary of Mayne Pharma Group Ltd, is a specialty pharmaceutical company that manufactures and markets branded and generic medicinal products. The company’s products comprise erymax capsules, kapanol capsules, …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆